Viewing Company Ceapro Inc. | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.

Ceapro Inc. Stock Symbol: CZO-X

Last Price Recorded: $1.6200 on 2017-02-24

Globe 5 day average
Google Discussions (view only)
yahoo discussion
Bloomberg
Date Signal Expert Opinion Price
2017-02-21 COMMENT Robert McWhirter

They extract the good stuff from oats for use in cosmetics. Also, extracts for use in food for reducing cholesterol. Recently increased their plant size by 10X. Still has a year’s worth of inventory stockpiled for covering risks with their new plant. There was some lumpiness in the most recent quarter with a Chinese customer not reordering. The question is, will he be back in the upcoming quarter. Thinks growth is pretty good with some interesting opportunities.


Price:
$1.620
Subject:
CANADIAN DIVIDEND & GROWTH
Bias:
BULLISH on OIL
Owned:
Unknown
2017-02-16 BUY Fabrice Taylor

He likes it.  You want to wait until they announce some big contracts.  If you own it hold on to it.  He would buy it here.  They are profitable.


Price:
$1.550
Subject:
NORTH AMERICAN
Bias:
SELECTIVE
Owned:
No
2017-01-24 PAST TOP PICK Jason Del Vicario

(A Top Pick July 4/16. Up 13.72%.) They take the active ingredients in oats and produce a compound that is an important ingredient in moisturizers and skin creams. Also, using this in a PGX technology so that it can be used in a powder formation as well. Opened a facility that will increase productivity tenfold. Last quarter was a titch weak, and suspects it was because large customers had ordered a lot of products in advance of opening the new facility. There are probably still growing pains. Trading range lately has been $1.20 - $2.00. Long term prospects are excellent.


Price:
$1.810
Subject:
NORTH AMERICAN (GROWTH)
Bias:
CAUTIOUSLY OPTIMISTIC
Owned:
Yes
2016-12-20 BUY Peter Imhof

He is one of the largest holders of the stock.  It came off because they did an issue.  They make chemicals that would go into a lot of P&G products.  The stock has been moving up in the last few days on a lot of volume.  There is still no analyst coverage.  He is comfortable with the story and thinks the next couple of quarters will show more strength.


Price:
$1.420
Subject:
NORTH AMERICAN - SMALL
Bias:
SELECTIVE
Owned:
Yes
2016-12-02 TOP PICK Fabrice Taylor

A biotech company, but they produce materials from oats. CEO is very impressive. Biotechs sometimes scares people, because they think they don’t make any money. This one actually makes money and is very profitable. They do 70% gross margins. Trading at about 12X earnings, and yet there is significant upside. The new plant can do 10X the revenue they currently do, so there is no CapX. As they fill the capacity use in that plant, it is going to be a free cash flow play. They are also testing different uses for the compound. Currently being used by Aveeno, but are also doing trial testing for combating high cholesterol. You are getting the stock for a very low multiple. Has $10 million cash in the bank.


Price:
$1.420
Subject:
NORTH AMERICAN - SMALL
Bias:
UNKNOWN
Owned:
Yes
2016-10-20 PAST TOP PICK Jason Del Vicario

(A Top Pick Aug 19/16. Down 7.53%.) They are consolidating. Just announced that they are opening a new facility in Edmonton. Have attracted some funding to be able to do some research in the new technology they are coming out with. He is keen on this.


Price:
$1.840
Subject:
NORTH AMERICAN (GROWTH)
Bias:
UNKNOWN
Owned:
Yes
2016-09-29 TOP PICK Peter Imhof

They extract beta glucan from oats.  It is supposed to be anti-aging, healing and goes into their products.  They have ramped up earnings tremendously over the last few quarters.  They just opened a new facility that can do 10 times the production.


Price:
$1.840
Subject:
NORTH AMERICAN - SMALL
Bias:
BULLISH on SMALL CAPS
Owned:
Yes
2016-08-19 PAST TOP PICK Jason Del Vicario

(A Top Pick July 4/16. Up 32.68%.) Has some very interesting patented technologies which removes an active ingredient from oats which is used in moisturizers. They also have a PGX technology that enables them to offer that product in a powder form. Growing their top and bottom lines very well. Has a new plant that should increase productivity 10X.


Price:
$1.990
Subject:
NORTH AMERICAN (GROWTH)
Bias:
CAUTIOUSLY OPTIMISTIC
Owned:
Yes
2016-08-19 TOP PICK Jason Del Vicario

Growing their top and bottom lines very well and are in a very, very interesting space. What he likes most is that their technology is patented, so they are able to license it out and collect royalties, as well as producing the products.


Price:
$1.990
Subject:
NORTH AMERICAN (GROWTH)
Bias:
CAUTIOUSLY OPTIMISTIC
Owned:
Yes
2016-08-19 COMMENT Michael Smedley

This sounds a bit sensible. Lots of imagination. It is probably very good, but you have to check with him again in the month’s time after he has had a look at it.


Price:
$1.990
Subject:
CANADIAN
Bias:
UNKNOWN
Owned:
No
2016-08-03 COMMENT Peter Hodson

Doesn’t follow this company, but only knows about up because it has gone up so much. Basically, they are using oats and bran malt for different applications, biotech, cosmetics, etc. Very early stage. Revenue growth is very, very high, but it is coming from a very small base. Revenue expectations are in the $20 million range, on a market cap of $145 million. Expectations are so high here, it’s early stage, and it’s a developing company. Investors need a splash of cold water, because they have jacked up the price so high. A decent little company, but just a crazy valuation.


Price:
$2.000
Subject:
CANADIAN SMALL & MIDCAPS
Bias:
BULLISH
Owned:
No
2016-07-21 COMMENT Robert McWhirter

The appeal of the stock is that it is in a non-cyclical industry. Has a proprietary process where they extract the good stuff from oatmeal. Also, has some other interesting technology. Has a new plant, which will increase their capacity by a factor of 10, which he expects to be up by the end of the year. Will be running the old plant to do custom work. Thinks there are pretty good barriers to entry. Upcoming earnings are supposed to be good, with acceleration into the 2nd half of the year. You should see this doing well on a 3-year basis.


Price:
$2.080
Subject:
CANADIAN DIVIDEND & GROWTH
Bias:
UNKNOWN
Owned:
Yes
2016-07-20 TOP PICK Peter Imhof

A very, very interesting company. Burt’s Bees, Aveeno and Neutrogena are some of its products. Has done an incredible job in the last 5 quarters. Revenue has gone from $1.7 million to $2.4 million to $3 million to $4 million last quarter, and income has risen quite a bit as well. There are no analysts looking at this now. Market cap has gotten over $100 million. Has a joint venture with a large German company. Thinks the next couple of quarters are going to be extremely good for them. Production is in Cdn$, but income is in US$.


Price:
$1.960
Subject:
NORTH AMERICAN - SMALL
Bias:
UNKNOWN
Owned:
Yes
2016-07-14 COMMENT Brendan Caldwell

Biotech name.  They are into a whole lot of different things involved in taking natural ingredients and commercializing them.  This is a very interesting junior company.


Price:
$1.530
Subject:
CANADIAN VALUE
Bias:
BULL
Owned:
No
2016-07-04 TOP PICK Jason Del Vicario

He likes that they have a patented process for extracting an active ingredient from oats for animal and human healthcare products.  They had a huge run and are consolidating now.  There is plenty of upside for them such as in the last year.


Price:
$1.530
Subject:
NORTH AMERICAN (GROWTH)
Bias:
SELECTIVE
Owned:
Yes
Showing 1 to 15 of 15 entries

No Comments.


You must be logged in to comment.